|
Jul 2
|
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options
|
|
Jun 30
|
Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)
|
|
Jun 29
|
Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025
|
|
Jun 27
|
Exploring Three High Growth Tech Stocks In The US Market
|
|
Jun 27
|
Aurinia (AUPH) Surges 7.5%: Is This an Indication of Further Gains?
|
|
Jan 22
|
Aurinia (AUPH) Upgraded to Buy: Here's Why
|